Zura Bio Limited Class A Ordinary Shares (ZURA) Stock Forecast & Price Target
Zura Bio Limited Class A Ordinary Shares · NASDAQ
$6.15-0.08 (-1.28%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Zura Bio Limited Class A Ordinary Shares, 6 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $11.00 to $22.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $17.20 sits 180% above the current $6.15. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.18 next quarter toward $-0.58 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Strong Buy
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Zura Bio Limited Class A Ordinary Shares.
As of Sep, 6 of 6 firms rate ZURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ZURA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.18
Range $-0.22 – $-0.11 · 3 analysts · -64% YoY
Next period, 3 analysts expect Zura Bio Limited Class A Ordinary Shares to earn $-0.18 a share (range $-0.22 – $-0.11), versus $-0.49 a year earlier. Full-year consensus is $-0.77, growing to $-0.58 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 3 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Zura Bio Limited Class A Ordinary Shares
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ZURA.
#1
Yatin Suneja
Guggenheim · Rank #21
Buy
$20.00+225.2% to target
Overall win rate
53%
+ Follow
#2
Daniil Gataulin
Chardan Capital · Rank #22
Buy
$11.00+78.9% to target
Overall win rate
58%
+ Follow
#3
Josh Schimmer
Cantor Fitzgerald · Rank #162
Buy
No targeton ZURA
Overall win rate
38%
+ Follow
#4
Yasmeen Rahimi
Piper Sandler · Rank #188
Buy
$26.00+322.8% to target
Overall win rate
33%
+ Follow
#5
Mitchell Kapoor
HC Wainwright & Co. · Rank #193
Hold
$2.00-67.5% to target
Overall win rate
34%
+ Follow
ZURA stock forecast FAQ
What is ZURA's average 12-month price target?+
The 5 analysts with a live target average $17.20 for Zura Bio Limited Class A Ordinary Shares over the next 12 months, ranging from a $22.00 high to a $11.00 low.
Is ZURA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 6 analyst ratings, 6 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ZURA?+
The Street-high target is $22.00 (Wedbush), and the Street-low is $11.00 (Chardan Capital). The average of all 5 active targets is $17.20.
How many Wall Street analysts cover ZURA?+
6 analysts have an active rating on Zura Bio Limited Class A Ordinary Shares, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering ZURA?+
Among analysts who currently cover ZURA, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #21). Their current call is Buy with a $20.00 target.
What is Zura Bio Limited Class A Ordinary Shares's projected EPS for next quarter?+
The consensus estimate is $-0.18 per share (range $-0.22 – $-0.11) across 3 analysts. Full-year EPS is projected at $-0.77, rising to $-0.58 the following year.
How much revenue is Zura Bio Limited Class A Ordinary Shares expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading ZURA lately?+
As of Sep, 6 of 6 firms rate ZURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ZURA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
